Lipid metabolism in metabolic-associated steatotic liver disease (MASLD)
MM Syed-Abdul - Metabolites, 2023 - mdpi.com
Metabolic-associated steatotic liver disease (MASLD) is a cluster of pathological conditions
primarily developed due to the accumulation of ectopic fat in the hepatocytes. During the …
primarily developed due to the accumulation of ectopic fat in the hepatocytes. During the …
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
G Tarantino, V Citro - Lipids in Health and Disease, 2024 - Springer
Liver fat storage, also called hepatic steatosis, is increasingly common and represents a
very frequent diagnosis in the medical field. Excess fat is not without consequences. In fact …
very frequent diagnosis in the medical field. Excess fat is not without consequences. In fact …
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH
Background & Aims Metabolic dysfunction-associated steatohepatitis (MASH) is one of the
most common liver diseases worldwide and is characterized by multi-tissue insulin …
most common liver diseases worldwide and is characterized by multi-tissue insulin …
[HTML][HTML] Targeting acetyl-CoA carboxylases for the treatment of MASLD
MA Mateo-Marín, M Alves-Bezerra - Journal of Lipid Research, 2024 - Elsevier
Hepatic accumulation of triglycerides is a hallmark feature of metabolic dysfunction-
associated steatotic liver disease (MASLD). Growing evidence indicates that increased rates …
associated steatotic liver disease (MASLD). Growing evidence indicates that increased rates …
Ketogenesis protects against MASLD-MASH progression through mechanisms that extend beyond overall fat oxidation rate
The progression of metabolic-dysfunction-associated steatotic liver disease (MASLD) to
metabolic-dysfunction-associated steatohepatitis (MASH) involves complex alterations in …
metabolic-dysfunction-associated steatohepatitis (MASH) involves complex alterations in …